Romania faces critical shortage of cytostatic oncology drugs due to funding and management failures

The National Association for Patient Protection (ANPP) reports a severe shortage of cytostatic drugs and the blockage of essential adjuvant oncology treatments in Romania. The ANPP attributes the crisis to government mismanagement and insufficient strategic reserves, despite increased revenue collection for the national health insurance fund.